Prism Medico and Pharmacy Ltd

Prism Medico Plans ₹25 Cr Capital Raise via Preferential Issue 📈

• Board approved issuance of up to 7,500,000 equity shares at ₹20 per share (₹15 crore total)

• Approved issuance of up to 5,000,000 convertible warrants at ₹20 per warrant (₹10 crore total)

• Allotment targets include Symbiosis Pharmaceuticals, Galaxy Vitacare, and individuals Sejal S Nashatar and Harsh Jentibhai Rupareliya

• Convertible warrants have a 1:1 conversion ratio, exercisable within 18 months of allotment

• Warrant terms: 25% payment upfront and 75% upon conversion